Unusual cardiac presentation of COVID-19 with significant sinus pauses

Chachar, Tarique Shahzad; Slais, Salman K.; Almadani, Abdulrahman; Hamad, Adel Khalifa Sultan

doi:10.37616/2212-5043.1226

Cited by 2 publications

(3 citation statements)

References 8 publications

(9 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

Section: Resultsmentioning

confidence: 99%

“…Table 2 presents the baseline demographics, diagnostic findings, and chief features of COVID‐19 patients who developed bradycardia from the individual cases compiled ( n = 59). 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 Bradycardia predominated in male patients ( n = 37) with a median age of 58.0 years old (IQR 48.0−71.0). Bradycardia was most often observed in patients classified as having severe or critical illness COVID‐19 (35.6% and 32.2%, respectively).…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Characteristics of bradyarrhythmia in patients with COVID‐19: Systematic scoping review

Nagamine

Randhawa

Nishimura

et al. 2022

Pacing Clinical Electrophis

View full text Add to dashboard Cite

COVID-19 has recently been associated with the development of bradyarrhythmias, although its mechanism is still unclear. We aim to summarize the existing evidence regarding bradyarrhythmia in COVID-19 and provide future directions for research.Following the PRISMA Extension for Scoping Reviews, we searched MEDLINE and EMBASE for all peer-reviewed articles using keywords including"Bradycardia," "atrioventricular block," and "COVID-19″ from their inception to October 13, 2021. Fortythree articles, including 11 observational studies and 59 cases from case reports and series, were included in the systematic review. Although some observational studies reported increased mortality in those with bradyarrhythmia and COVID-19, the lack of comparative groups and small sample sizes hinder the ability to draw definitive conclusions. Among 59 COVID-19 patients with bradycardia from case reports and series, bradycardia most often occurred in those with severe or critical COVID-19, and complete heart block occurred in the majority of cases despite preserved LVEF (55.9%).Pacemaker insertion was required in 76.3% of the patients, most of which were permanent implants (45.8%). This systematic review summarizes the current evidence and characteristics of bradyarrhythmia in patients with COVID-19. Further studies are critical to assess the reversibility of bradyarrhythmia in COVID-19 patients and to clarify potential therapeutic targets including the need for permanent pacing.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Characteristics of bradyarrhythmia in patients with COVID‐19: Systematic scoping review

Nagamine

Randhawa

Nishimura

et al. 2022

Pacing Clinical Electrophis

View full text Add to dashboard Cite

show abstract

“…It has ever since rapidly spread worldwide, causing morbidity and mortality in its way. In March 2020, the World Health Organization (WHO) declared the COVID-19 outbreak a pandemic [1,2]. In order to control the spread of "COVID-19", there was a need to develop vaccines very quickly and it culminated in the discovery of several potential vaccine candidates.…”

Section: Introductionmentioning

confidence: 99%

First Report of Acute Myocarditis Post-Pfizer-BioNTech COVID-19 Vaccination in the Kingdom of Bahrain

Chachar¹,

Yousuf²,

Sulaibikh³

et al. 2021

Cureus

View full text Add to dashboard Cite

We present a case of a 24-year-old male patient who presented to our institution five days after receiving his first dose of Pfizer-BioNTech vaccine to rule out acute coronary syndrome due to chest pain along with troponin increase and ECG changes. Acute coronavirus disease 2019 (COVID-19) infection was excluded based on a negative real-time reverse transcription-polymerase chain reaction (RT-PCR) test of specimens acquired using nasopharyngeal swabs for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and all other viral serologies were found to be negative. Coronary angiogram showed normal coronaries, and the presence of late gadolinium enhancement, which is indicative of myocarditis, was identified using cardiac magnetic resonance imaging (MRI). Our case report raises concern that the COVID-19 vaccine may cause myocarditis as a rare side effect.

show abstract

Unusual cardiac presentation of COVID-19 with significant sinus pauses

Abstract: There is growing evidence of cardiac complications due to corona virus disease 2019 (COVID 19). Our case is a case of a young patient with COVID-19 and symptomatic sinus pauses.

Cited by 2 publications

References 8 publications

Characteristics of bradyarrhythmia in patients with COVID‐19: Systematic scoping review

Characteristics of bradyarrhythmia in patients with COVID‐19: Systematic scoping review

First Report of Acute Myocarditis Post-Pfizer-BioNTech COVID-19 Vaccination in the Kingdom of Bahrain

Contact Info

Product

Resources

About